Abstract:Abstract Background: Forkhead box protein H1 (FOXH1) is upregulated in a variety of cancer types but its expression patterns and specific functions in lung cancer are unclear at present. The main objective of the present study was to establish whether FOXH1 plays a role in regulation of lung cancer progression. Methods: The TCGA and Kaplan-Meier plotter dataset was analyzed for possible association between FOXH1 expressions in lung cancer tissues and patient prognosis. A549 and PC9 cells were transfected with shRNA targeting FOXH1 mRNA. The Cell Counting Kit-8 (CCK8), plate clone formation, soft agar, wound healing, transwell invasion and flow cytometry assay were performed to detect the cell proliferation, migration and invasion in lung cancer cells. Tumorigenicity was examined in mouse model system. Western blot analysis was used to detect FOXH1, Matrix metalloproteinase 2 (MMP2), Vimentin, N-cadherin, E-cadherin, Snail, Slug, p-GSK-3β, β-catenin and Cyclin D1. The β-catenin activity was measured by luciferase reporter system assay. Results: FOXH1 expression in the lung cancer was determined using the TCGA and Kaplan-Meier plotter databases. Higher expression of FOXH1 was observed in tumor tissue relative to normal tissue, which was associated with reduced overall survival. FOXH1 knockdown resulted in significant inhibition of the proliferation, the cell cycle, the migration as well as the invasion of lung cancer cells. Then, we confirmed that FOXH1 knockdown can significantly slow down tumor growth and tumor cell proliferation in vivo using the mouse model. It also significantly reduced the migration and invasion capabilities of lung cancer cells. Using Western blot analyses, we found that FOXH1 depletion inhibited the epithelial-mesenchymal transition of lung cancer cells through downregulation of the mesenchymal cell markers Snail, Slug, MMP2, N-cadherin, and Vimentin, and upregulation of the epithelial marker E-cadherin. Moreover, FOXH1 knockdown significantly downregulated β-catenin and its downstream targets, such as p-GSK-3β and cyclin D1, and also led to direct suppression of β-catenin activity, as determined by the luciferase reporter system assay. Conclusion: In conclusion, FOXH1 promotes proliferation, migration, and invasion of lung cancer cells via regulation of Wnt/β-catenin signaling. FOXH1 is a prognostic marker and a potential therapeutic target for lung cancer treatment.

FOXM1 Promotes Head and Neck Squamous Cell Carcinoma Via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis.

FOXH1&nbsp;Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer&nbsp;

FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL

FOXM1 Promotes Proliferation in Human Hepatocellular Carcinoma Cells by Transcriptional Activation of CCNB1.

FOXH1 Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer

FOXA1-induced LINC01207 facilitates head and neck squamous cell carcinoma via up-regulation of TNRC6B

FOXH1 Promotes Lung Cancer Progression by Activating the Wnt/β-catenin Signaling Pathway

Knockdown of FOXM1 Suppresses Cell Growth and Metastasis in Human Laryngeal Cancer Via the AKT Signaling Pathway

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.

miR-30e-5p-mediated FOXD1 promotes cell proliferation by blocking cellular senescence and apoptosis through p21/CDK2/Rb signaling in head and neck carcinoma

FoxM1 Promotes Epithelial–mesenchymal Transition, Invasion, and Migration of Tongue Squamous Cell Carcinoma Cells Through a C-Met/akt-dependent Positive Feedback Loop

FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region

Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

LncRNA MNX1-AS1 Drives Aggressive Laryngeal Squamous Cell Carcinoma Progression and Serves As a Cerna to Target FoxM1 by Sponging Microrna-370

Foxm1 Overexpression Promotes Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma

Overexpression of FoxM1 is Associated with Tumor Progression in Patients with Clear Cell Renal Cell Carcinoma

FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.

Foxm1 Is Associated With Poor Prognosis Of Non-Small Cell Lung Cancer Patients Through Promoting Tumor Metastasis

LINC01614 Promotes Oral Squamous Cell Carcinoma by Regulating FOXC1

FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2